Core Viewpoint - Corning Jereh Pharmaceutical-B (09966.HK) has conducted a share buyback on November 17, purchasing 350,000 shares at a total cost of HKD 3.4198 million, indicating a strategic move to enhance shareholder value [1][2]. Group 1: Buyback Details - On November 17, the company repurchased 350,000 shares at prices ranging from HKD 9.640 to HKD 9.860 per share, with a closing price of HKD 9.790 on that day [1]. - The total trading volume for the stock on that day was HKD 15.6234 million [1]. - Year-to-date, the company has completed six buybacks, totaling 2.031 million shares and an aggregate expenditure of HKD 23.3849 million [2]. Group 2: Buyback Summary Table - The buyback details are as follows: - November 17: 350,000 shares at a maximum price of HKD 9.860 and a minimum price of HKD 9.640, costing HKD 3.4198 million - November 7: 560,000 shares at a maximum price of HKD 9.520 and a minimum price of HKD 9.240, costing HKD 5.2610 million - October 28: 320,000 shares at a maximum price of HKD 11.970 and a minimum price of HKD 11.530, costing HKD 3.7684 million - October 16: 400,000 shares at a maximum price of HKD 13.820 and a minimum price of HKD 13.520, costing HKD 5.4830 million - October 14: 293,000 shares at a maximum price of HKD 13.830 and a minimum price of HKD 13.030, costing HKD 3.9669 million - October 13: 108,000 shares at a maximum price of HKD 13.800 and a minimum price of HKD 13.690, costing HKD 1.4860 million [2].

Core Viewpoint - Corning Incorporated announced a share buyback of 350,000 shares for a total expenditure of HKD 3.4198 million, scheduled for November 17, 2025 [1] Group 1 - The company plans to repurchase shares, indicating confidence in its financial position and future prospects [1] - The total amount allocated for the buyback is approximately HKD 3.4198 million, reflecting a strategic move to enhance shareholder value [1] - The buyback involves 350,000 shares, which may influence the stock's liquidity and market perception [1]

Core Viewpoint - Corning Jereh Pharmaceutical-B (09966.HK) announced a share buyback of 350,000 shares at a cost of HKD 3.42 million on November 17 [1] Group 1 - The company executed a buyback program, indicating confidence in its stock value [1] - The total expenditure for the buyback was HKD 3.42 million [1] - The number of shares repurchased was 350,000 [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 康寧傑瑞生物製藥 呈交日期： 2025年11月17日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 09966 | 說明 | 普通股 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | | 已發行股份（ ...

Group 1 - The Hong Kong battery sector continues to strengthen, with Longpan Technology rising over 25% [1] - Ruipu Lanjun increased by more than 10% [1] - Ganfeng Lithium rose by over 9% [1] - Zhongchuang Xinhang and Tianqi Lithium both saw increases of over 8% [1]

Core Viewpoint - Corning Jereh Pharmaceutical-B has conducted share buybacks, indicating a strategy to enhance shareholder value amidst stock price fluctuations [2] Buyback Summary - On November 7, the company repurchased 560,000 shares at a price range of HKD 9.240 to HKD 9.520, totaling HKD 5.261 million [2] - The stock closed at HKD 9.470 on the same day, reflecting a decline of 9.29%, with a total trading volume of HKD 84.0624 million [2] - Year-to-date, the company has completed five buyback transactions, repurchasing a total of 1.681 million shares for a cumulative amount of HKD 19.9651 million [2] Detailed Buyback Information - Buyback details include: - November 7: 560,000 shares at a maximum price of HKD 9.520 and a minimum of HKD 9.240, totaling HKD 5.261 million - October 28: 320,000 shares at a maximum price of HKD 11.970 and a minimum of HKD 11.530, totaling HKD 3.7684 million - October 16: 400,000 shares at a maximum price of HKD 13.820 and a minimum of HKD 13.520, totaling HKD 5.483 million - October 14: 293,000 shares at a maximum price of HKD 13.830 and a minimum of HKD 13.030, totaling HKD 3.9669 million - October 13: 108,000 shares at a maximum price of HKD 13.800 and a minimum of HKD 13.690, totaling HKD 1.486 million [2]

Core Viewpoint - The company, Corning Incorporated, has announced a decision by its board to repurchase up to HKD 30 million of its ordinary shares from the open market, indicating a belief that the current share price does not accurately reflect its intrinsic value [1] Group 1 - The board believes that the share repurchase will demonstrate confidence in the company's business outlook and prospects [1] - The company asserts that the current financial resources are sufficient to support the proposed share buyback while maintaining a robust financial position [1]

Core Viewpoint - Corning Jereh Pharmaceutical-B (09966) announced a decision by its board to repurchase up to HKD 30 million of its ordinary shares from the open market, indicating that the current trading price does not accurately reflect the company's intrinsic value [1] Group 1 - The board believes that the share repurchase will demonstrate confidence in the company's business outlook and prospects, ultimately benefiting the company and creating value for its shareholders [1] - The company asserts that its current financial resources are sufficient to support the proposed share repurchase while maintaining a robust financial position [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不就因本公告全部或任何部分內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 ALPHAMAB ONCOLOGY 本公司董事（「董事」）會（「董事會」）有意宣佈，根據董事獲授出的一般授權（「股 份購回授權」，由股東於2025年6月12日舉行的股東週年大會上批准），董事會於 2025年11月7日決議不時自公開市場購回本公司普通股（「股份」），購回股份的金 額最高為30百萬港元。股份購回授權將持續有效，直至以下最早發生者為止：(i) 本公司下屆股東週年大會結束時；(ii)根據適用法律或本公司組織章程細則規定本 公司須舉行下屆股東週年大會期限屆滿時；或(iii)股東於本公司股東大會上以普 通決議案變更或撤銷該項授權時。股份購回授權的詳情載於本公司日期為2025年 5月21日的通函。 截至本公告日期，本公司根據股份購回授權購回1,681,000股股份並持作庫存股 份。股東及潛在投資者應注意，本公司之場內股份購回將視乎市況進行，並將由 董事會及╱或其授權人士全權酌情決定。概無法保證任何購回 ...

Core Viewpoint - Corning Jereh Pharmaceutical-B (09966) announced a share buyback of 560,000 shares for a total expenditure of HKD 5.261 million on November 7, 2025, with a buyback price range of HKD 9.24 to HKD 9.52 per share [1] Summary by Category - **Company Actions** - The company executed a buyback of 560,000 shares [1] - The total amount spent on the buyback was HKD 5.261 million [1] - The buyback price per share ranged from HKD 9.24 to HKD 9.52 [1]